This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
New Buyouts Aid Boston Scientific Amid Coronavirus Crisis
by Zacks Equity Research
The current economic turbulence due to the coronavirus outbreak is massively causing depreciation of Boston Scientific's (BSX) stock.
Here's Why You Should Hold on to LabCorp (LH) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about LabCorp (LH) on its strong segmental results in the fourth quarter of 2019.
Will Rescue Deal Impact Last? 4 Coronavirus-Proof Dividend Picks
by Urmimala Biswas
With the ongoing erratic movement of most stocks, it's a prudent idea for investors to go for dividend-paying stocks as a regular source of income.
Bull of the Day: Edwards Lifesciences (EW)
by Kevin Cook
While most elective procedures are being deferred, the innovator of minimally-invasive heart valve replacement beats on
QIAGEN Releases Coronavirus Test Kit in US on New FDA Policy
by Zacks Equity Research
QIAGEN (QGEN) releases test kits in the United States to speed up the diagnosis of coronavirus per the FDA's latest policy.
Medtronic (MDT) in Focus: Stock Moves 8% Higher
by Zacks Equity Research
Medtronic (MDT) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
Stellar Codman Surgical Sales Aid Integra Amid Supply Issues
by Zacks Equity Research
Completion of integration activities, scale expansion, product launches, and venturing into faster-growing markets drive Interga's (IART) sales within Codman Surgical.
New Buyouts & Envigo Deal Aid LabCorp Amid Regulatory Woes
by Zacks Equity Research
LabCorp's (LH) Covance arm grows on strategic acquisitions including MI Bioresearch.
Here's Why You Should Hold on to Insulet (PODD) Stock Now
by Zacks Equity Research
Investors remain confident in Insulet (PODD) stock on solid prospects.
Align Technology Gets FDA Nod for iTero Intraoral Scanner
by Zacks Equity Research
The regulatory go-ahead is expected to help bolster Align Technolgy's (ALGN) iTero scanner and services business segment.
GNC Holdings' (GNC) Q4 Loss Narrows, Gross Margin Expands
by Zacks Equity Research
GNC Holdings (GNC) registers gross margin expansion in Q4, while the operating margin contracts.
LabCorp Aims to Prioritize Inpatient Coronavirus Testing
by Debanjana Dey
LabCorp (LH) aims to serve the hospital inpatient population, with guidance provided by the CDC. It is also preparing to support faster point-of-care testing in hospitals.
Here's Why You Should Add Hill-Rom Stock to Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about Hill-Rom (HRC) on its strong domestic and international results in the first quarter of fiscal 2020.
Align's High Invisalign Volume Stokes Growth Amid Cost Woes
by Zacks Equity Research
Stellar growth in Align Technology's (ALGN) Invisalign Go systems across all geographies continues.
Exact Sciences Grows on New Deals, Down on Coronavirus Scare
by Zacks Equity Research
Exact Sciences (EXAS) progressing well in terms of the company's three priorities.
Here's Why You Should Hold on to NuVasive (NUVA) Stocks Now
by Zacks Equity Research
Investors continue to be optimistic about NuVasive (NUVA) on its strong segmental and international results in the fourth quarter of 2019.
Bio-Rad, Biodesix Partner to Get EUA for Coronavirus Test
by Zacks Equity Research
Bio-Rad (BIO) inks partnership deal with Biodesix to receive a EUA for a ddPCR test.
Here's Why You Should Retain Amedisys (AMED) Stock for Now
by Zacks Equity Research
Investor confidence is high in Amedisys (AMED) stock, thanks to solid prospects.
Quest Diagnostics Prioritizes Patients With Risk of Coronavirus
by Zacks Equity Research
The initiative will make Quest Diagnostics (DGX) one of the active players that are combating the public health crisis.
Ventilator Stocks Next Big Thing in Coronavirus-Hit Market?
by Urmimala Biswas
Tesla's Elon Musk holds discussion regarding ventilators production with Medtronic, likely to set foot in the ventilator-manufacturing space.
Zacks.com featured highlights include: Medtronic, STERIS and Enova International
by Zacks Equity Research
Zacks.com featured highlights include: Medtronic, STERIS and Enova International
Bio-Rad's ddPCR System Detects Coronavirus More Accurately
by Zacks Equity Research
Bio-Rad's (BIO) ddPCR System shows better sensitivity and precision in the detection of SARS-CoV-2, unlike existing qPCR tests.
3 Top Stocks to Buy for Earnings Acceleration
by Tirthankar Chakraborty
Studies have shown that a majority of stocks had seen acceleration in earnings before a rally in stock price.
Insulet Rides on DexCom Pact, Omnipod's Wider Market Reach
by Zacks Equity Research
Insulet (PODD) plans to expand Omnipod DASH across Europe and Canada, further uplifting market sentiment.
Medtronic (MDT) Down 34.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.